Drug
deucravacitinib
Marketed as SOTYKTU.
Generic name
deucravacitinib
Brand names
SOTYKTU
First FDA approval
2022-09-09
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA214958 | SOTYKTU | 2022-09-09 | BRISTOL |
Manufacturers
BRISTOL
Frequently asked questions
When was deucravacitinib FDA approved?
Earliest FDA approval on record: 2022-09-09.
What brand names are sold as deucravacitinib?
SOTYKTU.
Sources
Appeal a deucravacitinib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com